New foam treatment for adult eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new medicated foam (OPA-15406) to see if it works better than a plain foam for adults with eczema. It might help reduce skin redness and itching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have eczema (atopic dermatitis) for at least 3 years
- Your eczema must cover 5% to 40% of your body (excluding your scalp)
- Your eczema severity must be mild to moderate (a score of 2 or 3 on a 0-4 scale)
- You have not had a bad flare-up or allergic skin reaction in the last 28 days
- You have never used this specific foam (OPA-15406) before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a foam medication called OPA-15406 for children and infants with atopic dermatitis (eczema). It aims to see if the foam can help improve skin symptoms and is safe to use.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial tests an experimental tablet (LT-002-158) for adults with moderate-to-severe eczema that hasn't improved enough with standard creams. The goal is to see if the tablet is safe and helps control symptoms.
This trial tests an experimental cream or pill called ENV-294 in adults whose eczema is moderate to severe and hasn't gotten better with standard creams. It aims to see if ENV-294 can help control symptoms like itching and skin redness.
This trial tests an experimental drug called SIM0278 for people with moderate to severe atopic dermatitis (eczema). It aims to see if the drug can reduce skin symptoms and is safe to use.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.